Nonsteroidal MRA in T2D-associated CKD

Share

Program Content

Activities

  • Slides: MRA in T2D CKD
    Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • Finerenone in T2D CKD
    Evidence for Use of Finerenone in T2D-associated CKD
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2022

    Expires: August 03, 2023

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim and Eli Lilly